Scarica l'app Stockscreener
12.68
21.19%
-3.41
Dopo l'orario di chiusura:
12.77
0.09
+0.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$16.09
Aprire:
$13.31
Volume 24 ore:
2.69M
Relative Volume:
3.20
Capitalizzazione di mercato:
$986.16M
Reddito:
$1.64B
Utile/perdita netta:
$-495.80M
Rapporto P/E:
-1.98
EPS:
-6.404
Flusso di cassa netto:
$-45.25M
1 W Prestazione:
-21.34%
1M Prestazione:
-24.57%
6M Prestazione:
+33.05%
1 anno Prestazione:
-9.23%
Intervallo 1D:
$12.63
$14.00
Intervallo di 1 settimana:
$12.63
$16.77
Portata 52W:
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.68 | 1.25B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Downgrade | Argus | Buy → Hold |
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
IART vs. PEN: Which Stock Is the Better Value Option? - Zacks Investment Research
Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry - Yahoo Finance
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026 - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Stock Down 3.1% -- Now Undervalued? GF Score: 70/100 - GuruFocus
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 6.1% D - GuruFocus
3 Reasons IART is Risky and 1 Stock to Buy Instead - Yahoo Finance
Integra LifeSciences on Track to Complete FDA Remediation in 2026 - Minichart
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference - Yahoo Finance
Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART) - Seeking Alpha
Integra LifeSciences Holdings (IART) Peer Comparison – Compare with Others - Value Research
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery? - Yahoo Finance
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat
Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat
IART 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - TMX Newsfile
Integra LifeSciences (IART) Declines 1.23% to $17.68 as Shares Test Key Support LevelRating Change - careplusvn.com
Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings (IART) Returns To Profit As Fair Value Debate Stays In Focus - Yahoo Finance
integra lifesciences holdings corp Profit Warnings - RTTNews
Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan
Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences - Yahoo Finance
IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus
Integra: Q2 Earnings Snapshot - kare11.com
Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative
Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore
Earnings call transcript: Integra LifeSciences beats Q2 2026 EPS, shares fall premarket - Investing.com
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
Integra LifeSciences (NASDAQ:IART) Reaches New 12-Month HighShould You Buy? - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Integra Lifesciences Holdings Corp Azioni (IART) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):